Getting the Brain’s Attention

Today, the internet is a sensory free-for-all: Pop-up ads burst into articles every few paragraphs, stealing the screen with lollipop colors and music, shouting product information from unseen corners. The human body is not so different. Every fingernail, elbow, nostril, and eyebrow is constantly vying for the brain’s attention. “Right now, your little toe is sending signals up to your…
Read More
Throughout history, observations of structure, from Robert Hooke’s cells to the beaks of Charles Darwin’s finches, have been fundamental to our ability to understand how life works. This is particularly true in structural biology, a discipline dedicated to visualizing the molecular machines and components that underlie almost all of life’s processes. The efforts of structural biologists have spawned vast and…
Read More
A preventative treatment for Lyme disease is likely to start clinical trials in humans this year, with researchers fundraising for the work to move the treatment closer to market. Mark Klempner, a professor of medicine at University of Massachusetts Medical School, has been working for years to develop a drug treatment for preventing Lyme disease, identifying an antibody that could attack the bacteria…
Read More
Assistant Professor of Computer Science Xiaohui Liang is leading a four-year $1,179,714 National Institute on Aging (NIA)-funded research project to use Voice Assistant Systems, such as Amazon’s Alexa and Google Home, to detect early cognitive impairment. Early diagnosis of Alzheimer’s disease and related dementias in older adults living alone is essential for developing, planning, and ensuring adequate support at home for patients and their…
Read More

Beam Therapeutics, Base Editing Drug Developer, Raises $180M in IPO

Beam Therapeutics enjoyed a successful Wall Street debut Thursday, as the first base editing treatments developer to go public saw its shares surge 45% from its initial public offering (IPO) price before dipping to a 10% first-day gain, closing at $18.75. Founded in 2017 by gene editing pioneers, Beam Therapeutics raised gross proceeds of $180 million through its IPO of…
Read More
The Transplant Research Program (TxRP) at Boston Children’s Hospital is the only pediatric transplantation research program in the U.S committed to better understanding the molecular basis for organ rejection after transplantation in children. Within the last year, members of the TxRP have initiated a new initiative to extend the longevity of transplanted organs and to develop and use biomarkers for monitoring patients.…
Read More

Seeing Blood Stem Cells Where They Live

The stem cells found in bone marrow have saved the lives of thousands of leukemia patients through transplantation, as they are capable of making any type of blood cell. Yet there are roadblocks to understanding these blood stem cells in detail, as it has not been possible to study them at their source. Now, researchers at the Harvard Stem Cell…
Read More
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Rejuvenate Bio has secured an exclusive worldwide license from the Harvard Office of Technology Development to commercialize a gene therapy technology developed at the Wyss Institute and Harvard Medical School (HMS) to prevent and treat several age-related diseases in dogs, extending their overall healthspan. The announcement follows the publication in Proceedings of…
Read More
A business incubator working to improve the lives of patients with heart, lung, blood and sleep disorders is expanding its reach to the next generation of biotech and medical device entrepreneurs. The Center for Advancing Point of Care Technologies (CAPCaT) assists inventors developing technologies and medical devices to help patients with these conditions manage their well-being wherever they are. The goal is…
Read More